Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium

(1) PURPOSE: The advent of effective targeted therapy in BRAF(V600E) mutant lung adenocarcinomas necessitates further exploration of the unique clinical features and behavior of advanced stage BRAF mutant lung adenocarcinomas. (2) PATIENTS AND METHODS: We reviewed data from patients with advanced lu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Villaruz, Liza C., Socinski, Mark A., Abberbock, Shira, Berry, Lynne D., Johnson, Bruce E., Kwiatkowski, David J, Iafrate, A. John, Varella-Garcia, Marileila, Franklin, Wilbur A., Camidge, D. Ross, Sequist, Lecia V., Haura, Eric B., Ladanyi, Mark, Kurland, Brenda F., Kugler, Kelly, Minna, John D, Bunn, Paul A., Kris, Mark G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305000/
https://ncbi.nlm.nih.gov/pubmed/25273224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados